IN-DATE
0113330: Bard OptiFix AT Absorbable Fixation System, 30 Fasteners
Sign in to add this product to your favorites!
| Price: | $499.00 per box of 1 |
|---|---|
| In Stock: | 0 box of 1 |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
Related Items
QUICK VIEW
| MAXTACK30 - Size: 5.00mm $599.00 per box of 1 Medtronic MaxTack 5mm Motorized Hernia Mesh Fixation Device w/30 Violet Tacks, 7mm Tack Length Exp: 03-2028 Units in stock: 6 box of 1 | Order Qty |
QUICK VIEW
| 0113126 $499.00 per box of 1 Bard OptiFix Absorbable Fixation System, 30 Fasteners In-Date Out of Stock |
|
QUICK VIEW
| 0113127 $299.00 per box of 1 Bard OptiFix Absorbable Fixation System, 15 Fasteners Exp: 08-2026 Units in stock: 2 box of 1 | Order Qty |
Additional Details
BD Bard OptiFix™ AT Absorbable Fixation System with Articulating Technology
OptiFix™ AT is an articulating device that allows for traditional
straight fixation plus the option to articulate the tip to better access areas where mesh fixation may otherwise be difficult, such as locations close to the trocar.
AccessGUDID Info
- FDA Product Code: GDW
- FDA Product Code Name: Staple, implantable
- GMDN Term Code: 45027
- GMDN Term Name: Soft-tissue/mesh anchor, bioabsorbable
- GMDN Term Description: A bioabsorbable device designed to be implanted into ligaments or other soft tissues for soft-tissue approximation and/or to serve as a site of attachment for surgical mesh or sutures; it is not intended to anchor soft tissues to bone, nor repair cartilage, and is not intended for ophthalmic use. It is available in a variety of designs (e.g., screw-, punch-, staple-like) and is made of a polymer that can be chemically degraded via natural body processes. It is intended to create a fixed anchor point and is not a suture-based fastening device such as a T-fastener. It is typically implanted with the use of a specialized applicator which may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
